Evidence map›Paper›PMID 39425237›Full record

ArticleMicrobiome2024

Upper respiratory microbial communities of healthy populations are shaped by niche and age.

Susan Zelasko, Mary Hannah Swaney, Shelby Sandstrom, Timothy C Davenport, Christine M Seroogy, James E Gern, Lindsay R Kalan, Cameron R Currie

Abstract read
In one paragraph

Article in Microbiome, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. The porcine skin microbiome exhibits broad fungal antagonism.Fungal genetics and biology : FG & B · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Susan ZelaskoDepartment of Bacteriology, University of Wisconsin-Madison, Madison, WI, USA. szelasko@wisc.edu.
Mary Hannah SwaneyMicrobiology Doctoral Training Program, University of Wisconsin-Madison, Madison, WI, USA.
Shelby SandstromDepartment of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, WI, USA.
Timothy C DavenportDepartment of Bacteriology, University of Wisconsin-Madison, Madison, WI, USA.
Christine M SeroogyDepartment of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
James E GernDepartment of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Lindsay R KalanDepartment of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, WI, USA.
Cameron R CurrieDepartment of Bacteriology, University of Wisconsin-Madison, Madison, WI, USA. ccurrie@mcmaster.ca.

Funding

University of Wisconsin Institute for Clinical and Translational ResearchUL1TR002373 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI ELIZABETH S BURNSIDE, Allan R. Brasier · 2017 to 2026
$75.9M
Novel antimicrobials targeting MDR pathogens from animal microbial symbiontsU19AI142720 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI SAFDAR, NASIA · 2019 to 2023
$30.1M
Wisconsin Infant Study Cohort (WISC)U19AI104317 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI Irene M Ong · 2013 to 2026
$22.5M
NRSA Training CoreTL1TR002375 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI Vivek Prabhakaran · 2017 to 2026
$8.4M
Microbial Pathogenesis &Host Responses Training ProgramT32AI055397 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI KLEIN, BRUCE STEVEN · 2003 to 2024
$5.5M
Identification of antimicrobial specialized metabolites from the human oral microbiome to target multidrug-resistant pathogensF30AI169759 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI ZELASKO, SUSAN · 2023 to 2024
$79k
NCATS NIH HHS TL1 TR002375NCATS NIH HHS UL1 TR002373NIAID NIH HHS F30 AI169759NIAID NIH HHS T32 AI055397NIAID NIH HHS U19 AI104317NIAID NIH HHS U19 AI142720NIH HHS F30AI169759NIH HHS T32AI055397NIH HHS U19AI104317NIH HHS U19AI142720
6 · The paper itself

Abstract

backgroundAlterations in upper respiratory microbiomes have been implicated in shaping host health trajectories, including by limiting mucosal pathogen colonization. However, limited comparative studies of respiratory microbiome development and functioning across age groups have been performed. Herein, we perform shotgun metagenomic sequencing paired with pathogen inhibition assays to elucidate differences in nasal and oral microbiome composition and intermicrobial interactions across healthy 24-month-old infant (n = 229) and adult (n = 100) populations.

resultsWe find that beta diversity of nasal and oral microbiomes varies with age, with nasal microbiomes showing greater population-level variation compared to oral microbiomes. Infant microbiome alpha diversity was significantly lower across nasal samples and higher in oral samples, relative to adults. Accordingly, we demonstrate significant differences in genus- and species-level composition of microbiomes between sites and age groups. Antimicrobial resistome patterns likewise varied across body sites, with oral microbiomes showing higher resistance gene abundance compared to nasal microbiomes. Biosynthetic gene clusters encoding specialized metabolite production were found in higher abundance across infant oral microbiomes, relative to adults. Investigation of pathogen inhibition revealed greater inhibition of gram-negative and gram-positive bacteria by oral commensals, while nasal isolates had higher antifungal activity.

conclusionsIn summary, we identify significant differences in the microbial communities inhabiting nasal and oral cavities of healthy infants relative to adults. These findings inform our understanding of the interactions impacting respiratory microbiome composition and functions related to colonization resistance, with important implications for host health across the lifespan. Video Abstract.

Indexed as

BacteriaMicrobiotaMouthAdultAge FactorsChild, PreschoolFemaleHealthy VolunteersHumansInfantMaleMetagenomeMetagenomicsRespiratory System

Identifiers

PMID39425237
PMCPMC11490146

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.